Coastline Trust Co Sells 3,335 Shares of Aflac Incorporated (NYSE:AFL)

Coastline Trust Co decreased its holdings in Aflac Incorporated (NYSE:AFL - Free Report) by 5.7% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 55,183 shares of the financial services provider's stock after selling 3,335 shares during the quarter. Coastline Trust Co's holdings in Aflac were worth $5,708,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Forum Financial Management LP lifted its holdings in shares of Aflac by 5.8% during the fourth quarter. Forum Financial Management LP now owns 8,831 shares of the financial services provider's stock valued at $913,000 after acquiring an additional 487 shares during the period. GeoWealth Management LLC raised its stake in shares of Aflac by 32.0% in the fourth quarter. GeoWealth Management LLC now owns 7,390 shares of the financial services provider's stock valued at $764,000 after acquiring an additional 1,793 shares during the last quarter. Canada Pension Plan Investment Board boosted its holdings in shares of Aflac by 339.7% in the 4th quarter. Canada Pension Plan Investment Board now owns 303,454 shares of the financial services provider's stock worth $31,389,000 after acquiring an additional 234,439 shares in the last quarter. Capital Square LLC acquired a new stake in Aflac during the 4th quarter valued at $205,000. Finally, Zacks Investment Management grew its holdings in shares of Aflac by 3.4% during the fourth quarter. Zacks Investment Management now owns 19,446 shares of the financial services provider's stock worth $2,012,000 after purchasing an additional 631 shares during the last quarter. Institutional investors own 67.44% of the company's stock.

Insider Buying and Selling at Aflac

In related news, Director Charles D. Lake II sold 29,802 shares of the company's stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the transaction, the director now directly owns 49,962 shares of the company's stock, valued at approximately $5,360,422.98. This represents a 37.36 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Joseph L. Moskowitz sold 1,000 shares of Aflac stock in a transaction on Friday, March 7th. The shares were sold at an average price of $107.63, for a total transaction of $107,630.00. Following the completion of the sale, the director now directly owns 25,393 shares of the company's stock, valued at approximately $2,733,048.59. The trade was a 3.79 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.90% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on the stock. Keefe, Bruyette & Woods decreased their price objective on shares of Aflac from $107.00 to $104.00 and set a "market perform" rating on the stock in a report on Wednesday, February 12th. Barclays reduced their price objective on Aflac from $98.00 to $95.00 and set an "underweight" rating on the stock in a report on Friday, February 7th. Morgan Stanley cut their price target on Aflac from $105.00 to $100.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 10th. UBS Group boosted their price objective on Aflac from $109.00 to $114.00 and gave the stock a "neutral" rating in a report on Wednesday, April 2nd. Finally, Piper Sandler increased their price objective on shares of Aflac from $118.00 to $124.00 and gave the company an "overweight" rating in a report on Wednesday, April 2nd. Two analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat.com, Aflac currently has a consensus rating of "Hold" and an average target price of $103.93.

Aflac Price Performance

Shares of Aflac stock traded up $0.63 on Thursday, reaching $109.06. 841,905 shares of the stock were exchanged, compared to its average volume of 1,992,444. Aflac Incorporated has a one year low of $80.59 and a one year high of $115.50. The firm has a market cap of $59.52 billion, a PE ratio of 11.36, a P/E/G ratio of 3.24 and a beta of 0.81. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10. The firm's 50 day moving average is $106.95 and its 200-day moving average is $107.18.

Aflac (NYSE:AFL - Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. As a group, analysts anticipate that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.